TRAW - Traws Pharma Inc
Traws Pharma Inc Logo

TRAW - Traws Pharma Inc

https://www.trawspharma.com
Momentum: Bearish
Recent News
Powered by Alpha Vantage
AI Tools
Key Metrics
Trend: Downtrend
Source: Snapshot

Traws Pharma, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing novel products to treat cancer in the United States. The company is headquartered in Newtown, Pennsylvania.

52W High
$15.00
52W Low
$0.97
MA Status:
50D: Below 200D: Below
Beta (~1 neutral, <0.9 lower risk)
1.52
Valuation
Attractive
As of 2025-06-30 (Overview)
Trailing P/E (<15 better)
0.43
Forward P/E (<15 better)
N/A
EV/EBITDA (<8 favorable)
0.33
EV/Revenue (<3 favorable)
1.25
P/S (TTM) (<3 favorable)
4.36
P/B (<3 favorable)
1.53
Ownership
Retail‑heavy
Source: Overview
Insiders (1–5% typical)
14.86%
Institutions (25–75% balanced)
17.89%
Shares Outstanding
7,063,800
Float
6,025,900
Dividend Yield (2–6% sweet spot)
N/A
Ex‑Dividend Date
N/A
Income & Growth
Profitability: Weak
As of 2025-06-30 (Overview)
Revenue (TTM)
2,903,000
Gross Profit (TTM)
2,903,000
EPS (TTM)
4.19
Profit Margin (>10% good)
N/A
Operating Margin (TTM) (higher better)
-0.46%
ROE (TTM) (>15% strong)
-2.48%
EPS YoY (Quarterly) (>10% good)
N/A
Revenue YoY (Quarterly) (>8% good)
46.95
Momentum
Bearish momentum
Value
0.1206
Previous
0.1070
Trend
Rising
Signal Cross
No cross
As of
Sep. 12, 2025